Featured
Benefit High Beam
Reader Review of the Day: Benefit Cosmetics high beam
Highlighters are great, so don't just save them for special occasions; use them everyday for that wide-awake glow.
So, for today's reader review, we're looking at Benefit Cosmetics high beam ($24), a brightening complexion enhancer. Reader A Million Suns is loving this product, calling it an ethereal glow in a bottle.
Get a Healthy Glow: Highlighters
Ever wonder how celebrities all get that healthy, radiant glow? Most likely, it's because their makeup artist is using a face illuminator, like Benefit's High Beam and Moon Beam complexion highlighters. These products can be used as spot enhancers or blended all over your face for a glowing, sexy look.
Backstage Pass To LFW Spring 2010: Mattijis
On Friday afternoon, the buzz backstage at the Mattijis van Bergen show all about a creating a fun loving, sexy and Summery feel. Hair was pulled back and teased in the front to create a kind of frizzy, wind-blown effect, whilst makeup was controlled yet luminous using toned down metallics. My pal, the friendly makeup artist Rachel Wood said,
"Because the designer is using copper and bronze jewellery, I wanted to complement the look and accent the eyes with that same colour scheme.
Prostate cancer
In This Report- Highlights
- Introduction
- Prognosis
- Risk Factors
- Symptoms
- Conditions with Similar Sym...
- Screening and Diagnosis
- Tests to Determine Severity...
- Treatment
- Treatment Options by Stagin...
- Treatment for Localized Pro...
- Surgery
- Radiation Treatments
- Options if Treatments Fail...
- Other Treatments
- Resources
- References
- Patients should be classified as low, intermediate, or high risk, depending on their PSA levels, cancer stage, and tumor aggressiveness.
- Doctors need to consider patients’ personal preferences and quality of life concerns as well as their clinical status.
- Standard treatment options include active surveillance (watchful waiting), surgery, or radiation therapy. Initial androgen deprivation therapy (hormone therapy) is seldom recommended for localized prostate cancer.
- The American Society of Clinical Oncology (ASCO) 2007 guidelines recommend that doctors delay androgen deprivation therapy for advanced prostate cancer until patients develop symptoms.
Brain tumors - primary
In This Report- Highlights
- Introduction
- Symptoms
- Risk Factors
- Causes
- Prognosis
- Diagnosis
- Common Brain Tumors
- Treatment
- Surgery
- Radiotherapy
- Chemotherapy
- Other Treatments
- Treatment of Complications...
- Resources
- References
- Radiation therapy in children with cancer increases the risk of new brain and spinal cord tumors, suggests a study in the Journal of the National Cancer Institute. The risk appears to increase along with the radiation dosage. Children who receive radiotherapy before age 5 are especially at risk for second primary tumors.
- Survivors of childhood brain tumors who received cranial radiotherapy as part of their treatment are at risk for later having a stroke, indicates a study in the Journal of Clinical Oncology.
Non-small cell lung cancer
In This Report- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Lifestyle Changes
- Diagnostic Tests
- Staging Systems
- Surgical Procedures
- Radiation Treatments
- Treatment Options by Stages...
- Chemotherapy Treatments
- Investigative Agents
- Resources
- References
- About 3,000 nonsmokers die each year of lung cancer resulting from exposure to secondhand smoke, according to a 2006 Surgeon General report.
- Advexin, a genetic therapy that contains the p53 tumor-suppressor gene, is showing promise. A 2006 study in Japan found that out of 13 patients with advanced NSCLC receiving Advexin, 10 had stabilized. Advexin is in Phase II clinical trials for NSCLC.
- Studies are finding that NSCLC tumors in people who never smoked have a much higher rate of epithelial growth-factor receptor (EGFR) mutations.
Cervical cancer
In This Report- Highlights
- Introduction
- Causes
- Risk Factors
- Prognosis
- Symptoms
- Prevention
- Diagnosis
- Treatment for Cervical Intr...
- Treatment for Cervical Canc...
- Treatment for Invasive Cerv...
- Resources
- References
Colon and rectal cancers
In This Report- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Dietary Factors
- Prevention
- Diagnosis
- Staging
- Prognosis
- Surgery
- Medications
- Radiation Treatment
- Follow-up Testing
- Treatment for Metastasized ...
- Resources
- References
Breast cancer
In This Report- Highlights
- Introduction
- Risk Factors
- Prevention and Lifestyle Fa...
- Symptoms
- Diagnosis
- Prognosis
- Treatment
- Surgery
- Radiation
- Medications
- Chemotherapy
- Hormone Therapy
- Resources
- References
- In September 2007, Evista (raloxifene) was approved for prevention of breast cancer in postmenopausal women with osteoporosis, and postmenopausal women at high risk for invasive breast cancer. Raloxifene and tamoxifen are the only two drugs approved for breast cancer prevention in high-risk women.
- In March 2007, lapatinib (Tykerb) was approved in combination with capecitabine (Xeloda) for treatment of advanced HER2-positive breast cancer.
- In November 2006, trastuzumab (Herceptin) was approved for treatment of early-stage HER2-positive breast cancer. Trastuzumab is also approved for advanced HER2-positive breast cancer.
- The American College of Physicians’ 2007 guidelines recommend that women with a low risk for breast cancer talk to their doctor before starting to have mammogram screening at age 40.
Coronary artery disease
In This Report- Highlights
- Introduction
- Prognosis
- Risk Factors
- Diagnosis
- Managing Heart Disease
- Anti-Clotting Medications...
- Other Medications
- Surgery
- Coronary Artery Bypass Graf...
- Angioplasty and Stents
- Other Treatments
- Resources
- References
- Stents coated with drugs may have a slightly higher risk of causing blood clots than bare metal stents, according to FDA meetings held in late 2006.
More on PopSugar
Holiday
Top Brands
Dress for Less
Vive Maria
Les Nereides